- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Global Pharmaceuticals & Biotech Potentially Undervalued Companies
UPDATED Mar 30, 2024
Companies with a Value score of at least 3, ordered by Value score
1,889 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
INDV | UK£16.94 | 3.0% | 22.3% | UK£2.3b | UK£24.82 | PE1452.7x | E32.8% | 0% | ||
0Y5E | US$32.25 | 2.3% | -8.6% | US$4.4b | US$38.82 | PB0.9x | E47.2% | 3.4% | ||
600062 | CN¥20.67 | 0.6% | 19.9% | CN¥21.1b | CN¥24.91 | PE15.8x | E11.2% | 1.2% | ||
0QFP | Ft9,311.25 | -0.1% | 27.9% | Ft1.7t | Ft11,579.29 | PE10.7x | E16.9% | 4.2% | ||
FOLD | US$11.78 | 2.2% | 6.2% | US$3.5b | US$19.00 | PS8.7x | E55.0% | n/a | ||
INDV | UK£21.42 | 2.6% | 27.8% | UK£2.3b | UK£31.39 | PE1452.7x | E32.8% | 0% | ||
SCYX | US$1.47 | 5.8% | -51.0% | US$55.5m | US$7.13 | PE0.8x | E-13.6% | n/a | ||
JUSH.F | US$0.73 | -0.4% | 40.4% | US$142.9m | US$1.08 | PE-2.2x | S6.2% | n/a | ||
INDVL | UK£17.10 | 4.3% | 23.6% | UK£2.3b | UK£25.06 | PE1452.7x | E32.8% | 0% | ||
KHTR.F | CA$3.92 | 0.8% | 19.3% | CA$536.2m | CA$4.91 | PS1.6x | E58.4% | n/a | ||
ALKS | US$27.07 | -0.8% | -4.0% | US$4.5b | US$34.83 | PE8.7x | E-16.1% | n/a | ||
AMRX | US$6.06 | -0.2% | 336.0% | US$1.9b | US$7.31 | PB94.5x | E104.9% | 0% | ||
PRGO | US$32.19 | 2.8% | -10.3% | US$4.4b | US$38.75 | PB0.9x | E47.2% | 3.4% | ||
2096 | HK$5.31 | -2.4% | -35.6% | HK$13.8b | HK$8.81 | PE4.1x | E-29.6% | 3.3% | ||
600557 | CN¥20.74 | -4.9% | -35.2% | CN¥12.1b | CN¥25.17 | PE22.6x | E18.0% | 1.8% | ||
ICY | US$52.54 | -1.0% | -19.1% | US$12.8b | US$70.10 | PE21.4x | E20.1% | n/a | ||
0J9P | US$56.88 | -1.3% | -21.1% | US$12.8b | US$75.89 | PE21.4x | E20.1% | n/a | ||
A069620 | ₩121,300.00 | 1.7% | 15.3% | ₩1.4t | ₩156,625.00 | PE11.5x | E-3.4% | 0.5% | ||
867 | HK$8.22 | -33.5% | -33.7% | HK$20.2b | HK$17.85 | PE7.7x | E21.7% | 5.2% | ||
867 | HK$8.22 | -33.5% | -33.7% | HK$20.2b | HK$17.85 | PE7.7x | E21.7% | 5.2% | ||
A3DTP0 | US$0.085 | 0% | -83.0% | US$1.3m | n/a | PB0.2x | E2.9% | n/a | ||
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | ||
SNCE | US$5.75 | 0.3% | 30.9% | US$34.7m | US$13.83 | PB0.7x | E66.7% | n/a | ||
TSMR.F | JP¥25.86 | 0% | n/a | JP¥290.3b | JP¥32.42 | PE17.3x | E17.1% | 1.8% |